Joseph Podolski resigned as president, CEO and board member of Repros Therapeutics Inc. to pursue other interests.
Larry Dillaha, CEO of CavtheRx, has been appointed to serve as interim president and CEO, effective Feb. 2.
Repros CEO resigns; interim CEO named
Gauging Supply Chain Risk In Volatile Times
Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals
The Future of Risk Management Digitization in Credit Risk Management
Climate Credit Analytics: Diving into the model